Cited by 58Xenotransplantation and immune responseBlood groups and transfusionGlycosylation and Glycoproteins Research

Anti-Neu5Gc and anti-non-Neu5Gc antibodies in healthy humans

Open access
Gao, Bingsi, Long, Cassandra, Lee, Whayoung, Zhang, Zhongqiang, Gao, Xiaotian, Landsittel, Doug, Ezzelarab, Mohamed, Ayares, David +4 more·2017·PLOS ONE

Abstract

Our group previously investigated the levels of anti-Gal and anti-nonGal IgM and IgG in a cohort of 75 healthy humans of various backgrounds, and found some significant differences related to factors such as age, gender, ABO blood group, diet, vaccination history, and geographic location during childhood. We have now expanded our cohort (n = 84) to investigate the levels of anti-Neu5Gc and anti-nonGal/nonNeu5Gc antibodies in healthy humans. Anti-nonGal and anti-nonGal/nonNeu5Gc human IgM and IgG binding to pRBCs and pAECs from GTKO/CD46 and GTKO/CD46/Neu5GcKO pigs were measured by flow cytometry. Anti-Gal and anti-Neu5Gc IgM and IgG levels were measured by ELISA. In summary, (i) the great majority (almost 100%) of humans had anti-Neu5Gc IgM and IgG antibodies that bound to pAECs and approximately 50% had anti-Neu5Gc antibodies that bound to pRBCs, (ii) there was significantly less human antibody binding to pig cells that did not express either Gal or Neu5Gc compared with those that did not express Gal alone, (iii) the levels of both IgM and IgG binding to GTKO/CD46/Neu5GcKO pRBCs and pAECs were low, (iv) the level of anti-Neu5Gc IgG was higher in men than women, (v) the level did not change with age or diet, and there was some variability associated with (vi) previous vaccination history and (vii) the geographic region in which the individual spent his or her childhood. Our study confirms that human antibody binding to RBCs and AECs from GTKO/CD46/Neu5GcKO pigs is greatly reduced compared to binding to GTKO/CD46 cells. However, all humans appear to have a low level of antibody that binds to pAECs that is not directed to either Gal or Neu5Gc. Our findings require consideration in planning clinical trials of xenotransplantation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0180768

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Xenogeneic sialic acids are one of the leading non-α-gal antigens, participating in the rejection of xenografts.

    “Xenogeneic sialic acids are one of the leading non-α-gal antigens, participating in the rejection of xenografts [133–135].”

    From Immunogenicity of decellularized extracellular matrix scaffolds: a bottleneck in tissue engineering and regenerative medicine (2023) · cites this paper as [135]

    The Results report that removing Neu5Gc from pig cells already lacking Gal substantially reduced human antibody binding, supporting Neu5Gc as an important non-Gal antigen. The paper does not establish that Neu5Gc participates in xenograft rejection; its findings concern antibody binding to cells, not graft rejection. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 39

  1. [1]Galili U, Shohet SB, Kobrin E, Stults CL, Macher BA. Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem. 1988; 263: 17755– 62.. 2460463
  2. [2]Good AH, Cooper DK, Malcolm AJ, Ippolito RM, Koren E, Neethling FA, et al Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc. 1992; 24: 559– 62.. 1566430
  3. [3]Oriol R, Ye Y, Koren E, Cooper DK. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation. 1993; 56: 1433– 42.. 8279016
  4. [4]Kobayashi T, Cooper DK. Anti-Gal, alpha-Gal epitopes, and xenotransplantation. Subcell Biochem. 1999; 32: 229– 57.. 10391998
  5. [5]Lexer G, Cooper DK, Rose AG, Wicomb WN, Rees J, Keraan M, et al Hyperacute rejection in a discordant (pig to baboon) cardiac xenograft model. J Heart Transplant. 1986; 5: 411– 8.. 3302173
  6. [6]Cooper DK, Human PA, Lexer G, Rose AG, Rees J, Keraan M, et al Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J Heart Transplant. 1988; 7: 238– 46.. 3290407
  7. [7]Ye Y, Neethling FA, Niekrasz M, Koren E, Richards SV, Martin M, et al Evidence that intravenously administered alpha-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts. Transplantation. 1994; 58: 330– 7.. 8053057
  8. [8]Phelps CJ, Koike C, Vaught TD, Boone J, Wells KD, Chen SH, et al Production of alpha 1,3-galactosyltransferase-deficient pigs. Science. 2003; 299: 411– 4. PubMed Central PMCID: PMCPMC3154759. doi: 10.1126/science.1078942 12493821 PMC3154759 · DOI
  9. [9]Kuwaki K, Tseng YL, Dor FJ, Shimizu A, Houser SL, Sanderson TM, et al Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med. 2005; 11: 29– 31. doi: 10.1038/nm1171. 15619628 · DOI
  10. [10]Yamada K, Yazawa K, Shimizu A, Iwanaga T, Hisashi Y, Nuhn M, et al Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med. 2005; 11: 32– 4. doi: 10.1038/nm1172. 15619627 · DOI
  11. [11]Higginbotham L, Mathews D, Breeden CA, Song M, Farris AB 3rd, Larsen CP, et al Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model. Xenotransplantation. 2015; 22: 221– 30. PubMed Central PMCID: PMCPMC4930152. doi: 10.1111/xen.12166 25847130 PMC4930152 · DOI
  12. [12]Iwase H, Liu H, Wijkstrom M, Zhou H, Singh J, Hara H, et al Pig kidney graft survival in a baboon for 136 days: longest life-supporting organ graft survival to date. Xenotransplantation. 2015; 22(4): 302– 9. doi: 10.1111/xen.12174; PubMed Central PMCID: PMCPMC4519393. 26130164 PMC4519393 · DOI
  13. [13]Iwase H, Hara H, Ezzelarab M, Li T, Zhang Z, Gao B, et al Immunological and physiological observations in baboons with life-supporting genetically engineered pig kidney grafts. Xenotransplantation. 2017; 24 doi: 10.1111/xen.12293; PubMed Central PMCID: PMCPMC5397334. 28303661 PMC5397334 · DOI
  14. [14]Mohiuddin MM, Singh AK, Corcoran PC, Thomas ML 3rd, Clark T, Lewis BG, et al Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft. Nat Commun. 2016; 7: 11138 PubMed Central PMCID: PMCPMC4822024. doi: 10.1038/ncomms11138 27045379 PMC4822024 · DOI
  15. [15]Kumar G, Satyananda V, Fang J, Zhou H, Fujita M, Ekser B, et al Is there a correlation between anti-pig antibody levels in humans and geographic location during childhood? Transplantation. 2013; 96: 387– 93. PubMed Central PMCID: PMCPMC3867204. doi: 10.1097/TP.0b013e3182992a84 23887601 PMC3867204 · DOI
  16. [16]Bouhours D, Pourcel C, Bouhours JE. Simultaneous expression by porcine aorta endothelial cells of glycosphingolipids bearing the major epitope for human xenoreactive antibodies (Gal alpha 1-3Gal), blood group H determinant and N-glycolylneuraminic acid. Glycoconj J. 1996; 13: 947– 53.. 8981086
  17. [17]Miwa Y, Kobayashi T, Nagasaka T, Liu D, Yu M, Yokoyama I, et al Are N-glycolylneuraminic acid (Hanganutziu-Deicher) antigens important in pig-to-human xenotransplantation? Xenotransplantation. 2004; 11: 247– 53. doi: 10.1111/j.1399-3089.2004.00126.x. 15099204 · DOI
  18. [18]Padler-Karavani V, Varki A. Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk. Xenotransplantation. 2011; 18: 1– 5. PubMed Central PMCID: PMCPMC3098739. doi: 10.1111/j.1399-3089.2011.00622.x 21342282 PMC3098739 · DOI · Paper page
  19. [19]Zhu A, Hurst R. Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum. Xenotransplantation. 2002; 9: 376– 81.. 12371933
  20. [21]Estrada JL, Martens G, Li P, Adams A, Newell KA, Ford ML, et al Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1/CMAH/beta4GalNT2 genes. Xenotransplantation. 2015; 22: 194– 202. PubMed Central PMCID: PMCPMC4464961. doi: 10.1111/xen.12161 25728481 PMC4464961 · DOI
  21. [22]Lee W, Miyagawa Y, Long C, Ekser B, Walters E, Ramsoondar J, et al Expression of NeuGc on Pig Corneas and Its Potential Significance in Pig Corneal Xenotransplantation. Cornea. 2016; 35: 105– 13. PubMed Central PMCID: PMCPMC4847538. doi: 10.1097/ICO.0000000000000635 26418433 PMC4847538 · DOI
  22. [23]Lee W, Hara H, Ezzelarab MB, Iwase H, Bottino R, Long C, et al Initial in vitro studies on tissues and cells from GTKO/CD46/NeuGcKO pigs. Xenotransplantation. 2016; 23: 137– 50. PubMed Central PMCID: PMCPMC4842123. doi: 10.1111/xen.12229 26988899 PMC4842123 · DOI
  23. [24]Long C, Hara H, Pawlikowski Z, Koike N, d'Arville T, Yeh P, et al Genetically engineered pig red blood cells for clinical transfusion: initial in vitro studies. Transfusion. 2009; 49: 2418– 29. doi: 10.1111/j.1537-2995.2009.02306.x. 19624491 · DOI
  24. [25]Hara H, Long C, Lin YJ, Tai HC, Ezzelarab M, Ayares D, et al In vitro investigation of pig cells for resistance to human antibody-mediated rejection. Transpl Int. 2008; 21: 1163– 74. doi: 10.1111/j.1432-2277.2008.00736.x. 18764834 · DOI
  25. [26]Zhang Z, Gao B, Zhao C, Long C, Qi H, Ezzelarab M, et al The impact of serum incubation time on IgM/IgG binding to porcine aortic endothelial cells. Xenotransplantation. 2017. in press. PMC5546950 28547819
  26. [27]Ezzelarab MB, Ekser B, Echeverri G, Hara H, Ezzelarab C, Long C, et al Costimulation blockade in pig artery patch xenotransplantation—a simple model to monitor the adaptive immune response in nonhuman primates. Xenotransplantation. 2012; 19: 221– 32. PubMed Central PMCID: PMCPMC3428748. doi: 10.1111/j.1399-3089.2012.00711.x 22909135 PMC3428748 · DOI
  27. [28]Yeh P, Ezzelarab M, Bovin N, Hara H, Long C, Tomiyama K, et al Investigation of potential carbohydrate antigen targets for human and baboon antibodies. Xenotransplantation. 2010; 17: 197– 206. doi: 10.1111/j.1399-3089.2010.00579.x. 20636540 · DOI
  28. [29]Galili U, Mandrell RE, Hamadeh RM, Shohet SB, Griffiss JM. Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun. 1988; 56: 1730– 7.; PubMed Central PMCID: PMCPMC259469. 3290105 PMC259469
  29. [30]Taylor RE, Gregg CJ, Padler-Karavani V, Ghaderi D, Yu H, Huang S, et al Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid. J Exp Med. 2010; 207: 1637– 46. PubMed Central PMCID: PMCPMC2916132. doi: 10.1084/jem.20100575 20624889 PMC2916132 · DOI
  30. [31]Chao SH, Chu SH, Lin CY, Hsieh RP, Chen KM. Epidemiologic profile of anti-pig natural antibodies in the Taiwan population. Transplant Proc. 1994; 26: 1369– 71.. 8029944
  31. [32]Hurh S, Kang B, Choi I, Cho B, Lee EM, Kim H, et al Human antibody reactivity against xenogeneic N-glycolylneuraminic acid and galactose-alpha-1,3-galactose antigen. Xenotransplantation. 2016; 23: 279– 92. doi: 10.1111/xen.12239. 27373998 · DOI
  32. [33]Springer GF, Horton RE. Blood group isoantibody stimulation in man by feeding blood group-active bacteria. J Clin Invest. 1969; 48: 1280– 91. PubMed Central PMCID: PMCPMC322351. doi: 10.1172/JCI106094 4893685 PMC322351 · DOI
  33. [34]Blixt O, Kumagai-Braesch M, Tibell A, Groth CG, Holgersson J. Anticarbohydrate antibody repertoires in patients transplanted with fetal pig islets revealed by glycan arrays. Am J Transplant. 2009; 9: 83– 90.
  34. [35]Padler-Karavani V, Yu H, Cao H, Chokhawala H, Karp F, Varki N, et al Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease. Glycobiology. 2008; 18: 818– 30. PubMed Central PMCID: PMCPMC2586336. doi: 10.1093/glycob/cwn072 18669916 PMC2586336 · DOI
  35. [36]Padler-Karavani V, Tremoulet AH, Yu H, Chen X, Burns JC, Varki A. A simple method for assessment of human anti-Neu5Gc antibodies applied to Kawasaki disease. PLoS One. 2013; 8: e58443 PubMed Central PMCID: PMCPMC3592828. doi: 10.1371/journal.pone.0058443 23520510 PMC3592828 · DOI
  36. [37]Byrne GW, Du Z, Stalboerger P, Kogelberg H, McGregor CG. Cloning and expression of porcine beta1,4 N-acetylgalactosaminyl transferase encoding a new xenoreactive antigen. Xenotransplantation. 2014; 21: 543– 54. PubMed Central PMCID: PMCPMC4262693. doi: 10.1111/xen.12124 25176027 PMC4262693 · DOI
  37. [38]Burlak C, Bern M, Brito AE, Isailovic D, Wang ZY, Estrada JL, et al N-linked glycan profiling of GGTA1/CMAH knockout pigs identifies new potential carbohydrate xenoantigens. Xenotransplantation. 2013; 20: 277– 91. PubMed Central PMCID: PMCPMC4593510. doi: 10.1111/xen.12047 24033743 PMC4593510 · DOI
  38. [39]Cooper DK, Hara H, Yazer M. Genetically engineered pigs as a source for clinical red blood cell transfusion. Clin Lab Med. 2010; 30: 365– 80. doi: 10.1016/j.cll.2010.02.001. 20513556 · DOI
  39. [41]Wang ZY, Martens GR, Blankenship RL, Sidner RA, Li P, Estrada JL, et al Eliminating Xenoantigen Expression on Swine RBC. Transplantation. 2017; 101: 517– 23. doi: 10.1097/TP.0000000000001302. 27379553 · DOI

Cited by

Sorted by citations

Authors
Gao, B., Long, C., Lee, W., Zhang, Z., Gao, X., Landsittel, D., Ezzelarab, M., Ayares, D., Huang, Y., Cooper, D. K. C., Wang, Y., & Hara, H.
Affiliations
  • University of Pittsburgh (US)
  • Central South University (CN)
  • University of South China (CN)
Corresponding author
  • Wang, Yi
  • Hara, Hidetaka
Venue
PLOS ONE
Published
2017-07-17
Volume
12
Issue
7
Pages
e0180768
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2735827335
Cited by
58
References
2
Citations by year
2026: 3 · 2025: 3 · 2024: 2 · 2023: 5 · 2022: 8 · 2021: 3 · 2020: 13 · 2019: 15 · 2018: 2 · 2017: 2 · 2013: 1
FWCI
8.97
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
National Institutes of Health (U19 AI090959, U01 AI068642, R21 A1074844)
Topics
  • Health Sciences › Medicine › Surgery › Xenotransplantation and immune response
  • Health Sciences › Medicine › Hematology › Blood groups and transfusion
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
Keywords
anti-Neu5Gc antibodies, anti-Gal antibodies, xenotransplantation, xenotransplantation rejection, porcine aortic endothelial cells, history of vaccination
MeSH terms
ABO Blood-Group System, Adult, Aged, Aged, 80 and over, Animals, Antibodies, Cells, Cultured, Diet, Erythrocytes, Female, Galactose, Galactosyltransferases, Humans, Mixed Function Oxygenases, Immunoglobulin G, Immunoglobulin M, Male, Middle Aged, Neuraminic Acids, Swine, Vaccination, Endothelial Cells, Membrane Cofactor Protein, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review